315 results
Page 7 of 16
8-K
EX-99.1
w62fmvjfo9wa31t
26 Jan 15
Alnylam Pharmaceuticals Prices Public Offering of Common Stock
12:00am
424B5
hx9yv48cw6dwr7x
21 Jan 15
Prospectus supplement for primary offering
12:00am
424B5
lfpk71ghxfrwd 830
20 Jan 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
d6ebnrr8e
8 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
ljwcrqnb78uuhgm
7 Aug 14
Alnylam Pharmaceuticals Reports Second Quarter 2014 Financial Results and Highlights Recent Period Activities
12:00am
8-K
EX-99.1
aius4ft g4
6 Mar 14
Alnylam Announces Closing of Previously Announced Acquisition of
12:00am
8-K
EX-99.1
crfv2aazb 8m15bsg4d
27 Feb 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
m1bly9xcktc
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
4pd0c11sedzataazn
13 Jan 14
Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck
12:00am